CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $411,605
- in 5 filings
Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-10 | RTW INVESTMENTS, LP Director | Purchase | +247,720 | $56.00 | $13.9M | 17,530,044 |
| 2020-10-05 | Patel Kinnari Chief Operating Officer | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2020-09-08 | Patel Kinnari Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-08-03 | Militello John | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2020-06-16 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-16 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-16 | WONG RODERICK Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2020-06-16 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-16 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +9,784 | $12.16 | $119K | 9,784 |
| 2020-06-16 | Makker Gotham Director | Grant or award · Stock Option (Right to Buy) | +3,206 | $12.16 | $39K | 3,206 |
| 2020-06-16 | Bjork Elisabeth Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-16 | Yalamanchi Naveen Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-06-16 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-04-20 | Bjork Elisabeth Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-03-24 | Shah Gaurav President & CEO | Exercise or conversion | +90,925 | $0.43 | $39K | 1,061,642 |
| 2020-03-24 | Shah Gaurav President & CEO | Shares withheld for taxes | −32,645 | $13.78 | $450K | 1,028,997 |
| 2020-03-24 | Shah Gaurav President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −90,925 | 0 | ||
| 2020-03-18 | Patel Kinnari Chief Operating Officer | Purchase | +1,000 | $9.50 | $10K | 6,675 |
| 2020-02-25 | Shah Gaurav President & CEO | Exercise or conversion | +290,000 | $0.43 | $126K | 976,950 |
| 2020-02-25 | Shah Gaurav President & CEO | Shares withheld for taxes | −6,233 | $20.15 | $126K | 970,717 |
Page 24 of 27 · 538 trades